| Ebtide Counseling Group, Inc | |
|
3100 University Blvd S Ste 218 Jacksonville FL 32216-2727 | |
| (904) 615-9037 | |
| Not Available |
| Full Name | Ebtide Counseling Group, Inc |
|---|---|
| Speciality | Social Worker |
| Location | 3100 University Blvd S Ste 218, Jacksonville, Florida |
| Authorized Official Name and Position | Ebony Davis (OWNER) |
| Authorized Official Contact | 9046159037 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ebtide Counseling Group, Inc 3100 University Blvd S Ste 218 Jacksonville FL 32216-2727 Ph: (904) 615-9037 | Ebtide Counseling Group, Inc 3100 University Blvd S Ste 218 Jacksonville FL 32216-2727 Ph: (904) 615-9037 |
| NPI Number | 1144871351 |
|---|---|
| Provider Enumeration Date | 09/28/2019 |
| Last Update Date | 09/28/2019 |
| Medicare PECOS PAC ID | 8527497809 |
|---|---|
| Medicare Enrollment ID | O20200408000792 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
A UCLA study has found that a new parent-training program is effective in reducing the risk of low-income, preschool-age Latino children being overweight.
A new study co-authored by investigators at the University of Massachusetts Medical School found that there is no correlation between opioids administered in the emergency room setting and Press Ganey ED patient satisfaction scores, one of the most commonly used metrics for measuring patient satisfaction.
Medtronic, Inc. today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received approval from the U.S. Food and Drug Administration (FDA) for an extended investigation to continue enrolling extreme risk patients under a Continued Access Study protocol.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to sales of Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma's Remicade, the two emerging TNF-alpha inhibitors Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma/Janssen's Simponi will drive sales of the TNF-alpha inhibitor drug class to nearly triple by 2018 for the treatment of ulcerative colitis.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144871351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Ebony R Davis |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1891293692 PECOS PAC ID: 5294096061 Enrollment ID: I20180719002594 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
A UCLA study has found that a new parent-training program is effective in reducing the risk of low-income, preschool-age Latino children being overweight.
A new study co-authored by investigators at the University of Massachusetts Medical School found that there is no correlation between opioids administered in the emergency room setting and Press Ganey ED patient satisfaction scores, one of the most commonly used metrics for measuring patient satisfaction.
Medtronic, Inc. today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received approval from the U.S. Food and Drug Administration (FDA) for an extended investigation to continue enrolling extreme risk patients under a Continued Access Study protocol.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to sales of Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma's Remicade, the two emerging TNF-alpha inhibitors Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma/Janssen's Simponi will drive sales of the TNF-alpha inhibitor drug class to nearly triple by 2018 for the treatment of ulcerative colitis.
› Verified 7 days ago
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
A UCLA study has found that a new parent-training program is effective in reducing the risk of low-income, preschool-age Latino children being overweight.
A new study co-authored by investigators at the University of Massachusetts Medical School found that there is no correlation between opioids administered in the emergency room setting and Press Ganey ED patient satisfaction scores, one of the most commonly used metrics for measuring patient satisfaction.
Medtronic, Inc. today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received approval from the U.S. Food and Drug Administration (FDA) for an extended investigation to continue enrolling extreme risk patients under a Continued Access Study protocol.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to sales of Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma's Remicade, the two emerging TNF-alpha inhibitors Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma/Janssen's Simponi will drive sales of the TNF-alpha inhibitor drug class to nearly triple by 2018 for the treatment of ulcerative colitis.
› Verified 7 days ago
Mark Dearing,lcsw Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12412 San Jose Blvd Ste 401, Jacksonville, FL 32223 Phone: 904-348-0343 | |
Reconnect Consulting Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3955 Riverside Ave, Jacksonville, FL 32205 Phone: 904-483-3843 | |
South Rehabilitation Center, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 580 Ellis Rd S, Suite 118, Jacksonville, FL 32254 Phone: 904-423-0017 Fax: 904-683-8169 | |
Mtb Therapist, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6034 Chester Ave, Jacksonville, FL 32217 Phone: 904-323-2019 | |
Mc Medical Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12100 Lem Turner Rd Unit 100, Jacksonville, FL 32218 Phone: 904-764-2855 Fax: 904-764-2670 | |
Westland Therapy Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6196 Lake Gray Blvd, Jacksonville, FL 32244 Phone: 718-483-5093 | |
Accessible Home Health Care Of South Central Massachusetts Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4131 University Blvd S Ste 10, Jacksonville, FL 32216 Phone: 508-769-2707 |